Curative treatment of RPS is predicated on complete macroscopic resection, but this is not appropriate in all cases, for a variety of tumour-, patient- and/or treatment-related reasons. Here we review the available literature to glean data that can guide patient selection for major extirpative surgery with its attendant risks or for palliative-intent management that emphasizes quality of life.
Keywords: Patient selection; resection; retroperitoneal sarcoma (RPS); tumor biology.